There are well-known prognostic and predictive factors, such as hormone receptor (estrogen receptor (ER), progesterone receptor (PR)) and human epidermal growth factor receptor 2 (HER2) status, as well as tumor proliferative index measured by Ki-67 expression, which influence the management and clinical outcome in BC. This evidence concerns the gene ESR1 and neoplasm.